| Hans-Günter Meyer-Thompson | Konsumräume
A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San Francisco, California, USA
A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San Francisco, California, USA
Amos Irwin, , Ehsan Jozaghi, Ricky N. Bluthenthal, Alex H. Kral
Journal of Drug Issues
First published date: December-13-2016
http://journals.sagepub.com/doi/full/10.1177/0022042616679829